• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破骨细胞中锌转运体ZIP1的表达。

Expression of the zinc transporter ZIP1 in osteoclasts.

作者信息

Khadeer Mohammed A, Sahu Surasri N, Bai Guang, Abdulla Sunia, Gupta Anandarup

机构信息

Department of Biomedical Sciences, Dental School, University of Maryland, 666 West Baltimore Street, Baltimore, MD 21201, USA.

出版信息

Bone. 2005 Sep;37(3):296-304. doi: 10.1016/j.bone.2005.04.035.

DOI:10.1016/j.bone.2005.04.035
PMID:16005272
Abstract

Zinc has been previously demonstrated to be a potent inhibitor of osteoclastogenesis and osteoclast function. The mechanisms for cellular uptake of zinc into osteoclasts have not been characterized. We have corroborated previous studies on the reduction of osteoclastogenesis in the presence of extracellular zinc. We demonstrate that osteoclasts express a ubiquitous plasma membrane zinc transporter, namely ZIP1, which was diffusely distributed throughout the cytoplasm. Following an adenoviral-mediated overexpression of ZIP1 in murine osteoclasts, ZIP1 was predominantly colocalized with actin at the sealing zone and significantly inhibited osteoclast function, as assessed by resorptive activity. Finally, overexpression of ZIP1 negatively impacted NF-kappaB binding activity, as assessed by electrophoretic mobility shift assays. In conclusion, these data both corroborate previous studies on regulation of osteoclast formation and activity by zinc and reveal the presence of a zinc uptake mechanism that exerts an important effect on osteoclast activity.

摘要

锌先前已被证明是破骨细胞生成和破骨细胞功能的有效抑制剂。锌进入破骨细胞的细胞摄取机制尚未明确。我们证实了先前关于细胞外锌存在时破骨细胞生成减少的研究。我们证明破骨细胞表达一种普遍存在的质膜锌转运体,即ZIP1,它在整个细胞质中呈弥散分布。在小鼠破骨细胞中通过腺病毒介导ZIP1过表达后,ZIP1主要在封闭区与肌动蛋白共定位,并通过吸收活性评估显著抑制破骨细胞功能。最后,通过电泳迁移率变动分析评估,ZIP1过表达对核因子κB结合活性产生负面影响。总之,这些数据既证实了先前关于锌对破骨细胞形成和活性调节的研究,又揭示了一种对破骨细胞活性有重要影响的锌摄取机制的存在。

相似文献

1
Expression of the zinc transporter ZIP1 in osteoclasts.破骨细胞中锌转运体ZIP1的表达。
Bone. 2005 Sep;37(3):296-304. doi: 10.1016/j.bone.2005.04.035.
2
Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells.ZIP1锌转运蛋白的过表达诱导间充质干细胞产生成骨表型。
Bone. 2006 Feb;38(2):181-98. doi: 10.1016/j.bone.2005.08.010. Epub 2005 Oct 3.
3
Momordin I, an inhibitor of AP-1, suppressed osteoclastogenesis through inhibition of NF-kappaB and AP-1 and also reduced osteoclast activity and survival.苦瓜素I,一种AP-1抑制剂,通过抑制NF-κB和AP-1抑制破骨细胞生成,还降低破骨细胞活性和存活率。
Biochem Biophys Res Commun. 2005 Nov 25;337(3):815-23. doi: 10.1016/j.bbrc.2005.09.113. Epub 2005 Sep 28.
4
NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.核因子-κB抑制剂去羟甲基环氧喹霉素可抑制小鼠关节炎中破骨细胞生成及活化T细胞核因子c1的表达,而不影响核因子κB受体活化因子配体、骨保护素或巨噬细胞集落刺激因子的表达。
Arthritis Res Ther. 2007;9(5):R97. doi: 10.1186/ar2298.
5
(-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB.(-)-表没食子儿茶素没食子酸酯通过核因子κB抑制破骨细胞分化
Biochem Biophys Res Commun. 2009 Feb 20;379(4):1033-7. doi: 10.1016/j.bbrc.2009.01.007. Epub 2009 Jan 14.
6
Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.表皮生长因子受体通过与RANK信号通路相互作用来调节破骨细胞的分化和存活。
J Cell Physiol. 2008 Nov;217(2):409-22. doi: 10.1002/jcp.21511.
7
Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.鹿茸的氯仿提取物可抑制破骨细胞分化和骨吸收。
J Ethnopharmacol. 2007 Sep 5;113(2):191-8. doi: 10.1016/j.jep.2007.04.020. Epub 2007 May 16.
8
Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos.咖啡酸苯乙酯通过抑制核因子κB和下调活化T细胞核因子c1及原癌基因c-Fos来抑制破骨细胞生成。
Int Immunopharmacol. 2009 Jun;9(6):774-80. doi: 10.1016/j.intimp.2009.03.001. Epub 2009 Mar 12.
9
Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.抗氧化剂α-硫辛酸通过降低核因子-κB与DNA的结合来抑制破骨细胞分化,并预防核因子-κB受体激活剂配体和肿瘤坏死因子-α诱导的体内骨吸收。
Free Radic Biol Med. 2006 May 1;40(9):1483-93. doi: 10.1016/j.freeradbiomed.2005.10.066. Epub 2005 Dec 9.
10
The mechanism of osteoclast differentiation induced by IL-1.白细胞介素-1诱导破骨细胞分化的机制。
J Immunol. 2009 Aug 1;183(3):1862-70. doi: 10.4049/jimmunol.0803007. Epub 2009 Jul 8.

引用本文的文献

1
Mechanism and regulatory strategy study on promoting vascularized bone regeneration via intracellular zinc ion transport.通过细胞内锌离子转运促进血管化骨再生的机制及调控策略研究
Bioact Mater. 2025 Aug 11;53:875-892. doi: 10.1016/j.bioactmat.2025.07.020. eCollection 2025 Nov.
2
An adaptive biodegradable zinc alloy with bidirectional regulation of bone homeostasis for treating fractures and aged bone defects.一种用于治疗骨折和老年骨缺损的具有骨稳态双向调节功能的自适应可生物降解锌合金。
Bioact Mater. 2024 May 6;38:207-224. doi: 10.1016/j.bioactmat.2024.04.027. eCollection 2024 Aug.
3
Zinc based biodegradable metals for bone repair and regeneration: Bioactivity and molecular mechanisms.
用于骨修复与再生的锌基可生物降解金属:生物活性与分子机制
Mater Today Bio. 2023 Dec 28;25:100932. doi: 10.1016/j.mtbio.2023.100932. eCollection 2024 Apr.
4
Iron, Zinc, Copper, Cadmium, Mercury, and Bone Tissue.铁、锌、铜、镉、汞与骨组织。
Int J Environ Res Public Health. 2023 Jan 26;20(3):2197. doi: 10.3390/ijerph20032197.
5
Effects of Extracellular Osteoanabolic Agents on the Endogenous Response of Osteoblastic Cells.细胞外成骨合成代谢药物对成骨细胞内源性应答的影响。
Cells. 2021 Sep 10;10(9):2383. doi: 10.3390/cells10092383.
6
Genome-Wide Integrated Analysis Revealed Functions of lncRNA-miRNA-mRNA Interaction in Growth of Intermuscular Bones in .全基因组综合分析揭示lncRNA-miRNA-mRNA相互作用在……肌间骨生长中的功能
Front Cell Dev Biol. 2021 Feb 4;8:603815. doi: 10.3389/fcell.2020.603815. eCollection 2020.
7
Involvement of Noncoding RNAs in the Differentiation of Osteoclasts.非编码RNA在破骨细胞分化中的作用
Stem Cells Int. 2020 Aug 25;2020:4813140. doi: 10.1155/2020/4813140. eCollection 2020.
8
Effect of zinc substitution in hydroxyapatite coating on osteoblast and osteoclast differentiation under osteoblast/osteoclast co-culture.羟基磷灰石涂层中锌替代对成骨细胞/破骨细胞共培养下成骨细胞和破骨细胞分化的影响。
Regen Biomater. 2019 Dec;6(6):349-359. doi: 10.1093/rb/rbz001. Epub 2019 Feb 8.
9
Zinc as a Therapeutic Agent in Bone Regeneration.锌作为骨再生的治疗剂。
Materials (Basel). 2020 May 12;13(10):2211. doi: 10.3390/ma13102211.
10
Zinc Homeostasis in Bone: Zinc Transporters and Bone Diseases.骨骼中的锌稳态:锌转运体与骨疾病。
Int J Mol Sci. 2020 Feb 12;21(4):1236. doi: 10.3390/ijms21041236.